References
- 1. H. Wulff, N. A. Castle and L. A. Pardo, Voltage-gated potassium channels as therapeutic targets, Nat. Rev. Drug Discov. 8(12) (2009) 982–1001; https://doi.org/10.1038/nrd2983
- 2. M. Bachmann, W. Li, M. J. Edwards, S. A. Ahmad, S. Patel, I. Szabo and E. Gulbins, Voltage-gated potassium channels as regulators of cell death, Front. Cell Dev. Biol. 8 (2020) Article ID 611853 (17 pages); https://doi.org/10.3389/fcell.2020.611853
- 3. C. Ashton, S. K. Rhie, J. D. Carmichael and G. Zada, Role of KCNAB2 expression in modulating hormone secretion in somatotroph pituitary adenoma, J. Neurosurg. 134(3) (2020) 1–7; https://doi.org/10.3171/2019.12.JNS192435
- 4. R. S. Herbst, D. Morgensztern and C. Boshoff, The biology and management of non-small cell lung cancer, Nature 553 (2018) 446–454; https://doi.org/10.1038/nature25183
- 5. M. Lu and Y. Su, Immunotherapy in non-small cell lung cancer: The past, the present, and the future, Thorac. Cancer 10(4) (2019) 585–586; https://doi.org/10.1111/1759-7714.13012
- 6. P. Friedl and K. Wolf, Tumour-cell invasion and migration: diversity and escape mechanisms, Nat. Rev. Cancer 3 (2003) 362–374; https://doi.org/10.1038/nrc1075
- 7. R. R. Langley and I. J. Fidler, The seed and soil hypothesis revisited – The role of tumor-stroma interactions in metastasis to different organs, Int. J. Cancer 128(11) (2011) 2527–2535; https://doi.org/10.1002/ijc.26031
- 8. L. L. Chen, N. Blumm, N. A. Christakis, A.-L. Barabási and T. S. Deisboeck, Cancer metastasis networks and the prediction of progression patterns, Br. J. Cancer 101(5) (2009) 749–758; https://doi.org/10.1038/sj.bjc.6605214
- 9. K. Ganesh and J. Massagué, Targeting metastatic cancer, Nat. Med. 27(1) (2021) 34–44; https://doi.org/10.1038/s41591-020-01195-4
- 10. R. L. Siegel, K. D. Miller and A. Jemal, Cancer statistics, 2020, CA. Cancer J. Clin. 70(1) (2020) 7–30; https://doi.org/10.3322/caac.21590
- 11. Y. Zhao and A. A. Adjei, New strategies to develop new medications for lung cancer and metastasis, Cancer Metastasis Rev. 34 (2015) 265–275; https://doi.org/10.1007/s10555-015-9553-5
- 12. H. H. Popper, Progression and metastasis of lung cancer, Cancer Metastasis Rev. 35 (2016) 75–91; https://doi.org/10.1007/s10555-016-9618-0
- 13. S. Kakiuchi, Y. Daigo, T. Tsunoda, S. Yano, S. Sone and Y. Nakamura, Genome-wide analysis of organ-preferential metastasis of human small cell lung cancer in mice., Mol. Cancer Res. 1(7) (2003) 485–499; Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12754296
- 14. L. Zhang, S. Bing, M. Dong, X. Lu and Y. Xiong, Targeting ion channels for the treatment of lung cancer, Biochim. Biophys. Acta Rev. Cancer 1876(2) (2021) Article ID 188629; https://doi.org/10.1016/j.bbcan.2021.188629
- 15. S. Roger, M. Potier, C. Vandier, P. Besson and J.-Y. Le Guennec, Voltage-gated sodium channels: new targets in cancer therapy?, Curr. Pharm. Des. 12(28) (2006) 3681–3695; https://doi.org/10.2174/138161206778522047
- 16. S. Roger, J. Rollin, A. Barascu, P. Besson, P.-I. Raynal, S. Iochmann, M. Lei, P. Bougnoux, Y. Gruel and J.-Y. Le Guennec, Voltage-gated sodium channels potentiate the invasive capacities of human non-small-cell lung cancer cell lines, Int. J. Biochem. Cell Biol. 39(4) (2007) 774–786; https://doi.org/10.1016/j.biocel.2006.12.007
- 17. L. Gillet, S. Roger, P. Besson, F. Lecaille, J. Gore, P. Bougnoux, G. Lalmanach and J.-Y. Le Guennec, Voltage-gated sodium channel activity promotes cysteine cathepsin-dependent invasiveness and colony growth of human cancer cells, J. Biol. Chem. 284(13) (2009) 8680–8691; https://doi.org/10.1074/jbc.M806891200
- 18. L. Brisson, V. Driffort, L. Benoist, M. Poet, L. Counillon, E. Antelmi, R. Rubino, P. Besson, F. Labbal, S. Chevalier, S. J. Reshkin, J. Gore and S. Roger, NaV1.5 Na+ channels allosterically regulate the NHE-1 exchanger and promote breast cancer cell invadopodial activity, J. Cell Sci. 126 (2013) 4835–4842; https://doi.org/10.1242/jcs.123901
- 19. L. WC Chow, K.-S. Cheng, K.-L. Wong and Y.-M. Leung, Voltage-gated K+ channels promote BT-474 breast cancer cell migration, Chinese J. Cancer Res. 30(6) (2018) 613–622; https://doi.org/10.21147/j.issn.1000-9604.2018.06.06
- 20. H. W. Park, M. S. Song, H. J. Sim, P. D. Ryu and S. Y. Lee, The role of the voltage-gated potassium channel, Kv2.1 in prostate cancer cell migration, BMB Reports 54(2) (2021) 130–135; https://doi.org/10.5483/BMBRep.2021.54.2.210
- 21. D. Aissaoui, S. Mlayah-Bellalouna, J. Jebali, Z. Abdelkafi-Koubaa, S. Souid, W. Moslah, H. Othman, J. Luis, M. ElAyeb, N. Marrakchi, K. Essafi-Benkhadir and N. Srairi-Abid, Functional role of Kv1.1 and Kv1.3 channels in the neoplastic progression steps of three cancer cell lines, elucidated by scorpion peptides, Int. J. Biol. Macromol. 111 (2018) 1146–1155; https://doi.org/10.1016/j.ijbiomac.2018.01.144
- 22. M. Spitzner, J. Ousingsawat, K. Scheidt, K. Kunzelmann and R. Schreiber, Voltage-gated K channels support proliferation of colonic carcinoma cells, FASEB J. 21 (2007) 35–44; https://doi.org/10.1096/fj.06-6200com
- 23. S. Y. Choi, H.-R. Kim, P. D. Ryu and S. Y. Lee, Regulation of voltage-gated potassium channels attenuates resistance of side-population cells to gefitinib in the human lung cancer cell line NCIH460, BMC Pharmacol. Toxicol. 18 (2017) Article ID 14 (9 pages); https://doi.org/10.1186/s40360-017-0118-9
- 24. B. J. Mans, Evolution of vertebrate hemostatic and inflammatory control mechanisms in blood-feeding arthropods, J. Innate Immun. 3(1) (2011) 41–51; https://doi.org/10.1159/000321599
- 25. J. M. C. Ribeiro and B. Arcà, From sialomes to the sialoverse: An insights into salivary potion of blood-feeding insects, Adv. In Insect Phys. Chapter 2, 59–118; https://doi.org/10.1016/S0065-2806(09)37002-2
- 26. A. C. P. Sousa, M. P. J. Szabó, C. J. F. Oliveira and M. J. B. Silva, Exploring the anti-tumoral effects of tick saliva and derived components, Toxicon 102 (2015) 69–73; https://doi.org/10.1016/j.toxicon.2015.06.001
- 27. B. Zhang, Z. Deng, B. Zeng, S. Yang, X. Chen, X. Xu and J. Wu, In-vitro effects of the FS50 protein from salivary glands of Xenopsylla cheopis on voltage-gated sodium channel activity and motility of MDA-MB-231 human breast cancer cells, Anticancer Drugs 29(9) (2018) 880–889; https://doi.org/10.1097/CAD.0000000000000662
- 28. Z. Deng, Q. Zeng, J. Tang, B. Zhang, J. Chai, J. F. Andersen, X. Chen and X. Xu, Anti-inflammatory effects of FS48, the first potassium channel inhibitor from the salivary glands of the flea Xenopsylla cheopis, J. Biol. Chem. 296 (2021) Article ID 100670 (16 pages); https://doi.org/10.1016/j.jbc.2021.100670
- 29. Q. Zeng, W. Lu, Z. Deng, B. Zhang, J. Wu, J. Chai, X. Chen and X. Xu, The toxin mimic FS48 from the salivary gland of Xenopsylla cheopis functions as a Kv1.3 channel-blocking immunomodulator of T cell activation, J. Biol. Chem. 298(1) (2022) Article ID 101497 (10 pages); https://doi.org/10.1016/j.jbc.2021.101497
- 30. W. I. Jeon, P. D. Ryu and S. Y. Lee, Effects of voltage-gated K+ channel blockers in gefitinib-resistant H460 non-small cell lung cancer cells., Anticancer Res. 32(12) (2012) 5279–5284; https://www.ncbi.nlm.nih.gov/pubmed/23225427
- 31. J. Wu, H. Zhang, X. Chen, J. Chai, Y. Hu, W. Xiong, W. Lu, M. Tian, X. Chen and X. Xu, FM-CATH, A novel cathelicidin from Fejervarya multistriata shows therapeutic potential for treatment of CLP-induced sepsis, Front. Pharmacol. 12 (2021) Article ID 731056 (13 pages); https://doi.org/10.3389/fphar.2021.731056
- 32. M. Song, S. Park, J. Park, J. Byun, H. Jin, S. Seo, P. Ryu and S. Lee, Kv3.1 and Kv3.4, are involved in cancer cell migration and invasion, Int. J. Mol. Sci. 19(4) (2018) Article ID 1061 (17 pages); https://doi.org/10.3390/ijms19041061
- 33. K. Silver, A. Littlejohn, L. Thomas, E. Marsh and J. D. Lillich, Inhibition of Kv channel expression by NSAIDs depolarizes membrane potential and inhibits cell migration by disrupting calpain signaling, Biochem. Pharmacol. 98(4) (2015) 614–628; https://doi.org/10.1016/j.bcp.2015.10.017
- 34. W. K. K. Wu, G. R. Li, T. M. Wong, J. Y. Wang, L. Yu and C. H. Cho, Involvement of voltage-gated K+ and Na+ channels in gastric epithelial cell migration, Mol. Cell. Biochem. 308 (2008) 219–226; https://doi.org/10.1007/s11010-007-9631-2
- 35. J. N. Rao, O. Platoshyn, L. Li, X. Guo, V. A. Golovina, J. X. J. Yuan and J.-Y. Wang, Activation of K+ channels and increased migration of differentiated intestinal epithelial cells after wounding, Am. J. Physiol. Physiol. 282 (2002) C885–C898; https://doi.org/10.1152/ajpcell.00361.2001
- 36. S.-H. Wu, Y.-T. Hsiao, C.-L. Kuo, F.-S. Yu, S.-C. Hsu, P.-P. Wu, J.-C. Chen, T.-C. Hsia, H.-C. Liu, W.-H. Hsu and J.-G. Chung, Bufalin inhibits NCI-H460 human lung cancer cell metastasis in vitro by inhibiting MAPKs, MMPs, and NF-κB pathways, Am. J. Chin. Med. 43(6) (2015) 1247–1264; https://doi.org/10.1142/S0192415X15500718
- 37. J. H. Kim, E. B. Cho, J. Lee, O. Jung, B. J. Ryu, S. H. Kim, J. Y. Cho, C. Ryou and S. Y. Lee, Emetine inhibits migration and invasion of human non-small-cell lung cancer cells via regulation of ERK and p38 signaling pathways, Chem. Biol. Interact. 242 (2015) 25–33; https://doi.org/10.1016/j.cbi.2015.08.014
- 38. C. Zhang, N. B. Leighl, Y.-L. Wu and W.-Z. Zhong, Emerging therapies for non-small cell lung cancer, J. Hematol. Oncol. 12(1) (2019) 1–24; https://doi.org/10.1186/s13045-019-0731-8